These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16824757)

  • 21. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
    Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
    Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of agonists and antagonists of the human melanocortin-4 receptor from piperazinebenzylamines.
    Tran JA; Pontillo J; Arellano M; White NS; Fleck BA; Marinkovic D; Tucci FC; Lanier M; Nelson J; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):833-7. PubMed ID: 15664867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
    Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
    J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity.
    Tran JA; Tucci FC; Jiang W; Marinkovic D; Chen CW; Arellano M; Markison S; Fleck BA; Wen J; White NS; Pontillo J; Saunders J; Marks D; Hoare SR; Madan A; Foster AC; Chen C
    Bioorg Med Chem; 2007 Aug; 15(15):5166-76. PubMed ID: 17544282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
    Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M; Renault J; Levoin N; Danvy D; Calmels T; Berrebi-Bertrand I; Robert P; Schwartz JC; Lecomte JM; Uriac P; Capet M
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5376-9. PubMed ID: 20708933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocortin-4 receptor agonists for the treatment of obesity.
    Boyce RS; Duhl DM
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1063-71. PubMed ID: 15535427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.
    Poitout L; Brault V; Sackur C; Bernetière S; Camara J; Plas P; Roubert P
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4464-70. PubMed ID: 17574418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonists.
    Tran JA; Arellano M; Fleck BA; Pontillo J; Marinkovic D; Tucci FC; Wen J; Saunders J; Chen C
    Med Chem; 2008 Jan; 4(1):67-74. PubMed ID: 18220971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia.
    Chen C; Jiang W; Tucci F; Tran JA; Fleck BA; Hoare SR; Joppa M; Markison S; Wen J; Sai Y; Johns M; Madan A; Chen T; Chen CW; Marinkovic D; Arellano M; Saunders J; Foster AC
    J Med Chem; 2007 Nov; 50(22):5249-52. PubMed ID: 17918824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
    Tran JA; Tucci FC; Arellano M; Jiang W; Chen CW; Marinkovic D; Fleck BA; Wen J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1931-8. PubMed ID: 18294847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonists.
    Vos TJ; Balani S; Blackburn C; Chau RW; Danca MD; Drabic SV; Farrer CA; Patane MA; Stroud SG; Yowe DL; Claiborne CF
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2302-5. PubMed ID: 16458508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.
    Pontillo J; Tran JA; Markison S; Joppa M; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Saunders J; Hoare SR; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 May; 15(10):2541-6. PubMed ID: 15863313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core.
    Xi N; Hale C; Kelly MG; Norman MH; Stec M; Xu S; Baumgartner JW; Fotsch C
    Bioorg Med Chem Lett; 2004 Jan; 14(2):377-81. PubMed ID: 14698163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.
    Heidler P; Zohrabi-Kalantari V; Calmels T; Capet M; Berrebi-Bertrand I; Schwartz JC; Stark H; Link A
    Bioorg Med Chem; 2005 Mar; 13(6):2009-14. PubMed ID: 15727854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.
    Bakshi RK; Hong Q; Tang R; Kalyani RN; Macneil T; Weinberg DH; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1130-3. PubMed ID: 16364639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.